University of Michigan hospital

Ann Arbor, Michigan 48109-5030

15 studies enrolling now · 125 studies all time

What they study most

ARDS, ARDS (Acute Respiratory Distress Syndrome), Abdominal Aortic Aneurysms, Acute Hepatitis, Acute Kidney Injury, Acute Neuropsychiatric Lupus, Acute Renal Allograft Rejection, Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), Adenocarcinoma of the Pancreas, Adenomyosis, Advanced Solid Tumors

Studies at this site

• A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart — Recruiting now
• Quantitative MRI for Myelofibrosis — Recruiting now
• A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• Impact of Intraoperative Oxygenation Practices on Patient Outcomes — Recruiting now
• Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition — Recruiting now
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
• The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study — Recruiting now
• A Retrospective Study to Characterize Participants With Propionic Acidemia — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• PRIMARY Ancillary Substudy — Recruiting now
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole — Stopped early
• Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer — Completed
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — Running, not enrolling
• GI Permeability Change in Response to Aquamin® — Completed
• Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
• Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) — Running, not enrolling
• GORE® CARDIOFORM Septal Occluder Migraine Clinical Study — Stopped early
• A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors — Running, not enrolling
• A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer — Completed
• Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) — Running, not enrolling
• Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer — Completed
• A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — Stopped early
• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early
• Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis — Completed
• The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy — Running, not enrolling
• Fimepinostat in Treating Brain Tumors in Children and Young Adults — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma — Running, not enrolling
• A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease — Completed
• Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer — APPROVED_FOR_MARKETING
• Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke — Completed
• Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer — Completed
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 — Stopped early
• Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer — Stopped early
• Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies — Completed
• A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures — Completed
• VISmodegib for ORbital and Periocular Basal Cell Carcinoma — Completed
• Zenith TX2® Post-market Approval Study — Completed
• ECPR for Refractory Out-Of-Hospital Cardiac Arrest — Completed
• Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery — Stopped early
• A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma — Completed
• Aquamin and Prevention of Colon Cancer — Completed
• Zenith® Dissection Clinical Trial — Completed
• QP ExCELs: MultiPole Pacing (MPP) Sub-Study — Completed